Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Nectar Lifesciences Ltd. ( (IN:NECLIFE) ) is now available.
Nectar Lifesciences Ltd. held its 30th Annual General Meeting (AGM) on September 29, 2025, via video conferencing, adhering to the relevant regulatory guidelines. The meeting, chaired by Managing Director Sanjiv Goyal, included participation from key directors and auditors. The AGM facilitated shareholder engagement and electronic voting, underscoring the company’s commitment to transparency and stakeholder involvement.
More about Nectar Lifesciences Ltd.
Nectar Lifesciences Ltd. operates in the pharmaceutical industry, focusing on the production and distribution of active pharmaceutical ingredients, formulations, and phytochemicals. The company is based in India and serves both domestic and international markets.
Average Trading Volume: 273,371
Technical Sentiment Signal: Sell
Current Market Cap: 3.26B INR
For detailed information about NECLIFE stock, go to TipRanks’ Stock Analysis page.